+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Anhydramnios in the Setting of Renal Malformations: The National Institutes of Health Workshop Summary



Anhydramnios in the Setting of Renal Malformations: The National Institutes of Health Workshop Summary



Obstetrics and Gynecology 131(6): 1069-1079



Anhydramnios in the setting of severe malformations of the fetal kidney and urinary tract is associated with a high incidence of stillbirths and life-threatening complications, including severe pulmonary hypoplasia, umbilical cord compression, and perinatal asphyxia. To prevent such adverse outcomes, some centers in the United States and elsewhere are offering amniotic fluid restoration for women diagnosed with anhydramnios in the setting of fetal renal malformations. The procedures include infusions of amniotic fluid substitutes (normal saline), percutaneously or through an amnioport-an implanted system for serial or continuous infusion of normal saline to maintain the desired amniotic fluid volume. The procedures are intended to prevent pulmonary hypoplasia and allow the pregnancy to progress closer to term gestation, enabling postnatal renal management, including long-term dialysis and renal transplantation. However, these procedures have not been recommended as standard of care by the professional societies because there are many knowledge gaps, including few data on short-term and long-term renal outcomes. The available diagnostic methods do not provide reliable prognostic information, and the current maternal and fetal interventions have not been standardized. To address these unresolved issues and to propose a research agenda, the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Diabetes and Digestive and Kidney Diseases invited a panel of experts to a workshop in August 2016. This report provides a summary of that meeting.

(PDF emailed within 0-6 h: $19.90)

Accession: 047529517

Download citation: RISBibTeXText

PMID: 29742659

DOI: 10.1097/AOG.0000000000002637


Related references

From The National Institutes of Health. Summary of the National Institutes of Health Research Workshop on the Epidemiology of the Acquired Immunodeficiency Syndrome (AIDS). Journal of Infectious Diseases 150(2): 295-303, 1984

National Institutes of Health workshop summary. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in individuals with asthma. Journal of Allergy and Clinical Immunology 76(2 Pt 1): 145-147, 1985

Summary of the joint National Institutes of Health/Renal Physician's Association workshop on dialysis, morbidity and mortality. American Journal of Kidney Diseases 21(1): 114-115, 1993

From the National Institute of Allergy and Infectious Diseases. Summary of the National Institutes of Health workshop on group B streptococcal infection. Journal of Infectious Diseases 148(1): 163-166, 1983

Measuring hot flashes: summary of a National Institutes of Health workshop. Mayo Clinic Proceedings 79(6): 777-781, 2004

Pigment gallstone disease: Summary of the National Institutes of Health--international workshop. Hepatology 2(6): 879-884, 1982

From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. Journal of Infectious Diseases 139(6): 728-734, 1979

Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 46(2): 566-581, 2007

Summary of workshop on drinking water fluoride influence on hip fracture on bone health. (National Institutes of Health, 10 April, 1991). Osteoporosis International 2(3): 109-117, 1992

Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. Journal of Urology 140(1): 203-206, 1988

Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013. Human Gene Therapy 25(6): 488-497, 2015

Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012. Human Gene Therapy 24(4): 355-362, 2014

Slow viruses and inborn metabolic errors. Summary of a workshop sponsored by the National Institutes of Health. Archives of Neurology 21(6): 645-648, 1969

Summary of the National Institutes of Health workshop on primary human immunodeficiency virus type 1 infection. Aids Research and Human Retroviruses 9(9): 913-924, 1993

Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop. Controlled Clinical Trials 22(5): 485-502, 2001